Details for Patent: 8,575,146
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,575,146 protect, and when does it expire?
Patent 8,575,146 protects RYDAPT and is included in one NDA.
This patent has twenty-eight patent family members in twenty-one countries.
Summary for Patent: 8,575,146
| Title: | Pharmaceutical uses of staurosporine derivatives |
| Abstract: | This application relates to the use of staurosporines derivatives for the curative, palliative or prophylactic treatment of allergic rhinitis, allergic dermatitis, drug allergy or food allergy, angioedema, urticaria, sudden infant death syndrome, bronchopulmonary aspergillosis, multiple sclerosis, or mastocytosis; and to a method of treatment of warm-blooded animals in which a therapeutically effective dose of a compound of a Staurosporine Derivative is administered to a warm-blooded animal suffering from one of the diseases or conditions mentioned above. |
| Inventor(s): | Coutre; Steven (Stanford, CA) |
| Assignee: | Novartis AG (Basel, CH) |
| Application Number: | 10/560,669 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,575,146 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 8,575,146
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | RYDAPT | midostaurin | CAPSULE;ORAL | 207997-001 | Apr 28, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | TREATMENT OF ADULT PATIENTS WITH AGGRESSIVE SYSTEMIC MASTOCYTOSIS (ASM), SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGICAL NEOPLASM (SM-AHN), OR MAST CELL LEUKEMIA (MCL) | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,575,146
| PCT Information | |||
| PCT Filed | June 17, 2004 | PCT Application Number: | PCT/EP2004/006562 |
| PCT Publication Date: | December 29, 2004 | PCT Publication Number: | WO2004/112794 |
International Family Members for US Patent 8,575,146
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 464052 | See Plans and Pricing | |||
| Australia | 2004248909 | See Plans and Pricing | |||
| Brazil | PI0411563 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
